Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 81
- −9 vs. Q1 2023
- Portfolio value
- $283.5M
- +$42.6M (+17.7%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SLRNACELYRIN, Inc. | COM | 2,918,426 | $61.0M | 21.5% | +2,918,426 | New | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 133,800 | $12.2M | 4.3% | +33,800+33.8% | Added | History |
| MRKMerck & Co., Inc. | Stock | 100,000 | $11.5M | 4.1% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 490,893 | $11.5M | 4.1% | +490,893 | New | History |
| NUVLNuvalent, Inc. | COM | 272,752 | $11.5M | 4.1% | +272,752 | New | History |
| IRONDisc Medicine, Inc. | COM | 240,031 | $10.7M | 3.8% | +240,031 | New | History |
| INSMINSMED Inc | COM PAR $.01 | 485,000 | $10.2M | 3.6% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 427,417 | $10.2M | 3.6% | +25,091+6.2% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 475,000 | $8.56M | 3.0% | +475,000 | New | History |
| IMGNImmunoGen, Inc. | COM | 447,700 | $8.45M | 3.0% | +447,700 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 429,686 | $7.39M | 2.6% | −165,000−27.7% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 140,000 | $6.99M | 2.5% | −85,000−37.8% | Reduced | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 611,932 | $6.65M | 2.3% | +611,932 | New | History |
| BMEABiomea Fusion, Inc. | COM | 275,875 | $6.06M | 2.1% | +64,900+30.8% | Added | History |
| RCUSArcus Biosciences, Inc. | COM | 280,000 | $5.69M | 2.0% | +50,000+21.7% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 121,658 | $5.61M | 2.0% | +121,658 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 135,486 | $5.22M | 1.8% | −25,000−15.6% | Reduced | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 203,037 | $5.18M | 1.8% | −4,075−2.0% | Reduced | History |
| ATXSAstria Therapeutics, Inc. | COM | 579,390 | $4.83M | 1.7% | −290,000−33.4% | Reduced | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 130,000 | $4.64M | 1.6% | +130,000 | New | History |
| LYRALyra Therapeutics, Inc. | COM | 978,626 | $4.02M | 1.4% | +634,941+184.7% | Added | History |
| LBPHLongboard Pharmaceuticals, Inc. | COM | 504,253 | $3.70M | 1.3% | +504,253 | New | History |
| VYGRVoyager Therapeutics, Inc. | COM | 300,000 | $3.44M | 1.2% | +300,000 | New | History |
| ALLKAllakos Inc. | COM | 772,092 | $3.37M | 1.2% | +772,092 | New | History |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 654,945 | $3.15M | 1.1% | +400,000+156.9% | Added | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 315,480 | $2.76M | 1.0% | −405,861−56.3% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 545,103 | $2.75M | 1.0% | +545,103 | New | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 174,510 | $2.46M | 0.9% | 00.0% | Unchanged | History |
| ESPREsperion Therapeutics, Inc. | COM | 1,705,605 | $2.37M | 0.8% | +350,000+25.8% | Added | History |
| ROIVRoivant Sciences Ltd. | SHS | 225,000 | $2.27M | 0.8% | −350,000−60.9% | Reduced | History |
| ACRSAclaris Therapeutics, Inc. | COM | 200,163 | $2.08M | 0.7% | −100,000−33.3% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 841,596 | $2.06M | 0.7% | 00.0% | Unchanged | History |
| BIVIBiovie Inc. | CL A NEW | 448,556 | $1.93M | 0.7% | +100,000+28.7% | Added | History |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 160,200 | $1.77M | 0.6% | +75,000+88.0% | Added | History |
| ELEVElevation Acquisition Group Inc. | COM | 1,149,490 | $1.75M | 0.6% | +1,149,490 | New | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 25,000 | $1.73M | 0.6% | +25,000 | New | History |
| MRUSMerus N.V. | COM | 63,125 | $1.66M | 0.6% | −145,525−69.7% | Reduced | History |
| IMUXImmunic, Inc. | COM | 650,000 | $1.63M | 0.6% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM | 1,125,087 | $1.54M | 0.5% | −1,200−0.1% | Reduced | History |
| SCPHscPharmaceuticals Inc. | COM | 150,000 | $1.53M | 0.5% | +150,000 | New | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 192,260 | $1.51M | 0.5% | 00.0% | Unchanged | History |
| BLUEbluebird bio, Inc. | COM | 412,628 | $1.36M | 0.5% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 460,416 | $1.31M | 0.5% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 140,000 | $1.26M | 0.4% | 00.0% | Unchanged | History |
| OKUROnKure Therapeutics, Inc. | COM | 155,819 | $1.02M | 0.4% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 35,000 | $966.7K | 0.3% | +35,000 | New | History |
| ARDXArdelyx, Inc. | COM | 278,825 | $945.2K | 0.3% | −300,000−51.8% | Reduced | History |
| TYRATyra Biosciences, Inc. | COM | 48,170 | $820.3K | 0.3% | 00.0% | Unchanged | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,765,530 | $804.8K | 0.3% | 00.0% | Unchanged | History |
| PRQRProQR Therapeutics N.V. | SHS EURO | 472,625 | $765.7K | 0.3% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 70,390 | $748.2K | 0.3% | +70,390 | New | History |
| COGTCogent Biosciences, Inc. | COM | 62,766 | $743.1K | 0.3% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 400,000 | $716.0K | 0.3% | +100,000+33.3% | Added | History |
| XFORX4 Pharmaceuticals, Inc | COM | 349,133 | $677.3K | 0.2% | 00.0% | Unchanged | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 260,087 | $619.0K | 0.2% | 00.0% | Unchanged | History |
| KYNBKyntra Bio, Inc. | COM | 228,420 | $616.7K | 0.2% | +228,420 | New | History |
| IMTXImmatics N.V. | SHS | 49,031 | $565.8K | 0.2% | −130,521−72.7% | Reduced | History |
| RETAReata Pharmaceuticals Inc | CL A | 5,472 | $557.9K | 0.2% | −75,092−93.2% | Reduced | History |
| HOOKHOOKIPA Pharma Inc. | COM | 600,000 | $528.0K | 0.2% | +600,000 | New | History |
| OCULOcular Therapeutix, Inc | COM | 100,000 | $516.0K | 0.2% | −100,000−50.0% | Reduced | History |
| TARAProtara Therapeutics, Inc. | COM STK | 188,664 | $450.9K | 0.2% | 00.0% | Unchanged | History |
| KODKodiak Sciences Inc. | COM | 62,527 | $431.4K | 0.2% | −100,000−61.5% | Reduced | History |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 189,935 | $391.3K | 0.1% | 00.0% | Unchanged | History |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 156,203 | $340.5K | 0.1% | 00.0% | Unchanged | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 221,830 | $303.9K | 0.1% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | 891,676 | $300.2K | 0.1% | +891,676 | New | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 213,392 | $279.5K | 0.1% | −23,317−9.9% | Reduced | History |
| PNTPOINT Biopharma Global Inc. | COM | 28,784 | $260.8K | 0.1% | −110,781−79.4% | Reduced | History |
| CNTBConnect Biopharma Holdings Ltd | ADS | 219,501 | $243.6K | 0.1% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 313,677 | $219.2K | 0.1% | +85,000+37.2% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 2,090 | $186.5K | 0.1% | +2,090 | New | History |
| MRSNMersana Therapeutics, Inc. | COM | 50,000 | $164.5K | 0.1% | +50,000 | New | History |
| RLMDRelmada Therapeutics, Inc. | COM | 65,491 | $161.1K | 0.1% | 00.0% | Unchanged | History |
| SYBXSynlogic, Inc. | COM | 306,757 | $131.9K | <0.1% | 00.0% | Unchanged | History |
| KDNYChinook Therapeutics, Inc. | COM | 283,464 | $130.4K | <0.1% | 00.0% | Unchanged | History |
| TECXTectonic Therapeutic, Inc. | COM | 134,146 | $127.5K | <0.1% | +134,146 | New | History |
| FHTXFoghorn Therapeutics Inc. | COM | 15,000 | $105.6K | <0.1% | +15,000 | New | History |
| FNCHFinch Therapeutics Group, Inc. | COM NEW | 7,917 | $67.5K | <0.1% | 00.0% | UnchangedConverted for a 1-for-30 split | History |
| Aslan Pharmaceuticals Ltd04522R200 | SPON ADS NEW | 164,088 | $29.8K | <0.1% | 00.0% | Unchanged | – |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 75 | $17.3K | <0.1% | 00.0% | Unchanged | History |
| Erytech Pharma29604W108 | SPONSORED ADR | 3,019 | $2.26K | <0.1% | −245,407−98.8% | Reduced | – |
Options (30)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | $51.5M | $14.8M |
| TGTXTG Therapeutics, Inc. | COM | $20.5M | $20.5M |
| BMEABiomea Fusion, Inc. | COM | $6.29M | $20.6M |
| BBIOBridgeBio Pharma, Inc. | COM | $2.58M | $21.2M |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | $11.2M | $11.2M |
| AZNAstraZeneca PLC | SPONSORED ADR | – | $17.9M |
| SRPTSarepta Therapeutics, Inc. | COM | $14.0M | $2.53M |
| REPLReplimune Group, Inc. | COM | $8.09M | $5.30M |
| VTYXVentyx Biosciences, Inc. | COM | $12.3M | – |
| APLSApellis Pharmaceuticals, Inc. | COM | $12.1M | – |
| PTGXProtagonist Therapeutics, Inc | COM | $5.84M | $5.52M |
| RETAReata Pharmaceuticals Inc | CL A | – | $11.2M |
| BMRNBiomarin Pharmaceutical Inc | COM | $8.67M | – |
| ACRSAclaris Therapeutics, Inc. | COM | $8.26M | – |
| IMVTImmunovant, Inc. | COM | $1.44M | $6.19M |
| IMGNImmunoGen, Inc. | COM | – | $6.60M |
| NVAXNovavax Inc | COM NEW | $2.97M | $2.97M |
| BHVNBiohaven Ltd. | COM | – | $5.38M |
| LEGNLegend Biotech Corp | SPONSORED ADS | – | $4.75M |
| INSMINSMED Inc | COM PAR $.01 | – | $4.22M |
| RCUSArcus Biosciences, Inc. | COM | – | $4.06M |
| STOKStoke Therapeutics, Inc. | COM | – | $2.29M |
| KYNBKyntra Bio, Inc. | COM | $1.02M | $1.08M |
| SLRNACELYRIN, Inc. | COM | – | $2.09M |
| DICEDICE Therapeutics, Inc. | COM | $2.03M | – |
| QUREuniQure N.V. | SHS | – | $1.77M |
| TERNTerns Pharmaceuticals, Inc. | COM | – | $1.75M |
| KRYSKrystal Biotech, Inc. | COM | $1.21M | – |
| MRSNMersana Therapeutics, Inc. | COM | – | $363.9K |
| NUVLNuvalent, Inc. | COM | – | $185.5K |
Sold out since Q1 2023 (34)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| RXDXPrometheus Biosciences, Inc. | COM | 125,926 | $13.5M | 5.6% | History |
| IMVTImmunovant, Inc. | COM | 774,398 | $12.0M | 5.0% | History |
| Bellus Health Inc New07987C204 | COM NEW | 885,334 | $6.37M | 2.6% | – |
| ISEEIVERIC bio, Inc. | COM | 213,521 | $5.19M | 2.2% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 50,000 | $4.86M | 2.0% | History |
| JBIOJade Biosciences, Inc. | COM | 195,146 | $3.94M | 1.6% | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 106,057 | $3.82M | 1.6% | History |
| State Street Health Care Select Sector SPDR ETF81369Y209 | ETF | 27,469 | $3.56M | 1.5% | – |
| ALTAltimmune, Inc. | COM NEW | 677,300 | $2.86M | 1.2% | History |
| BTAIQBioXcel Therapeutics, Inc. | COM | 133,014 | $2.48M | 1.0% | History |
| VTYXVentyx Biosciences, Inc. | COM | 65,000 | $2.18M | 0.9% | History |
| CYTKCytokinetics Inc | COM NEW | 55,666 | $1.96M | 0.8% | History |
| AKROAkero Therapeutics, Inc. | COM | 50,000 | $1.91M | 0.8% | History |
| MGNXMacrogenics Inc | COM | 250,000 | $1.79M | 0.7% | History |
| MORFMorphic Holding, Inc. | COM | 45,873 | $1.73M | 0.7% | History |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 46,462 | $1.40M | 0.6% | – |
| MRTXMirati Therapeutics, Inc. | COM | 33,100 | $1.23M | 0.5% | History |
| SRPTSarepta Therapeutics, Inc. | COM | 8,324 | $1.15M | 0.5% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 60,000 | $1.13M | 0.5% | History |
| DCTHDelcath Systems, Inc. | COM NEW | 360,569 | $1.08M | 0.4% | History |
| IVAInventiva S.A. | ADS | 292,599 | $999.2K | 0.4% | History |
| ACHVAchieve Life Sciences, Inc. | COM | 174,714 | $989.5K | 0.4% | History |
| SAGESage Therapeutics, Inc. | COM | 17,805 | $747.1K | 0.3% | History |
| VKTXViking Therapeutics, Inc. | COM | 43,156 | $718.5K | 0.3% | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 10,000 | $293.4K | 0.1% | History |
| BIIBBiogen Inc. | COM | 962 | $267.5K | 0.1% | History |
| ARK Innovation ETF00214Q104 | ETF | 4,519 | $182.3K | 0.1% | – |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 448,101 | $147.9K | 0.1% | – |
| SPPISpectrum Pharmaceuticals Inc | COM | 176,980 | $132.7K | 0.1% | History |
| Genfit S A372279109 | ADS | 32,786 | $131.5K | 0.1% | – |
| STSASatsuma Pharmaceuticals, Inc. | COM | 136,059 | $95.0K | <0.1% | History |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 367,112 | $60.0K | <0.1% | – |
| Bio Green Med Solution, Inc.23254L603 | COM | 275,000 | $11.0K | <0.1% | – |
| GOSSGossamer Bio, Inc. | COM | 6,100 | $7.69K | <0.1% | History |